EUVIMEDEUVIMED entdecken
Open Access

Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice

Kristen D Turner iD, Ying Qian iD, Dennis R Claflin iD, Breanne L Newell-Stamper, Angela K Peter iD, Daniel E Michele iD, Alan J Russell iD, Susan V Brooks iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00187.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Kristen D Turner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States. Hauptthemen laut MEDLINE: Pregnenediones, Muscular Dystrophy, Duchenne, Muscle, Skeletal, Cell Membrane Permeability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Edgewise Therapeutics, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanical instability of muscle fiber membranes is a hallmark feature of Duchenne muscular dystrophy (DMD). Glucocorticoids are commonly prescribed in DMD; however, effects on contraction-induced injury and associated mechanisms remain unclear. Here, 3 wk deflazacort in mdx mice substantially reduced Evans Blue dye uptake and the lengthening contraction-induced force decline in vivo and resulted in a strong trend toward blunted calcium uptake during damaging contractions ex vivo. These findings indicate that short-term deflazacort protects from contraction-induced injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregnenedionesMuscular Dystrophy, DuchenneMuscle, SkeletalCell Membrane PermeabilityMuscle StrengthAnimalsMice, Inbred mdxMiceMaleMice, Inbred C57BLMuscle Fibers, SkeletalMuscle ContractionDisease Models, Animal

Stichwörter der Autor:innen

deflazacortglucocorticoidsmuscular dystrophyskeletal muscle

Substanzen

Pregnenedionesdeflazacort

Autor:innen und Institutionen

  • Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States.
  • Edgewise Therapeutics, BioFrontiers Institute, University of Colorado, Boulder, Colorado, United States.
  • Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, United States.

ORCID-Profile: Kristen D Turner, Ying Qian, Dennis R Claflin, Angela K Peter, Daniel E Michele, Alan J Russell, Susan V Brooks

Förderung

  • Edgewise Therapeutics
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • NIAMS NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NIGMS NIH HHS

Zitieren

APA

Turner, K. D., Qian, Y., Claflin, D. R., Newell-Stamper, B. L., Peter, A. K., Michele, D. E., Russell, A. J., & Brooks, S. V. (2025). Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00187.2025

Vancouver

Turner KD, Qian Y, Claflin DR, Newell-Stamper BL, Peter AK, Michele DE, et al. Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00187.2025

BibTeX
@article{Turner2025,
  author = {Turner, Kristen D and Qian, Ying and Claflin, Dennis R and Newell-Stamper, Breanne L and Peter, Angela K and Michele, Daniel E and Russell, Alan J and Brooks, Susan V},
  title = {Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00187.2025}
}
Kostenlos starten →